CHCL

Cian Healthcare financials

Market cap
₹21 Cr

Quarterly results

Q4 FY26: revenue down 48.5%, net profit down 1700.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ4 FY22Q2 FY23Q4 FY23Q2 FY24Q4 FY24Q2 FY25Q4 FY25Q4 FY26
Revenue31 38 31 33 62 +100%19 −50%12 −61%17 −48%
EBITDA1 5 7 4 11 +1000%-1 −120%-5 −171%-3 −175%
Net profit-4 0 2 -1 0 +100%-18 -8 −500%-18 −1700%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance +294.4% 1Y

₹5.0₹10.0₹15.0Sept 25Oct 25Dec 25Apr 26Jul 26Aug 26

1Y: ₹3.74 on 9 Sept 2025 → ₹14.75. High ₹14.75 (10 Sept 2026), low ₹3.74 (9 Sept 2025).

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹23 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹25 Cr
Reserves₹35 Cr₹30 Cr₹32 Cr₹33 Cr₹7 Cr₹-16 Cr
Borrowings₹71 Cr₹63 Cr₹61 Cr₹56 Cr₹55 Cr₹29 Cr
Other liabilities₹28 Cr₹47 Cr₹42 Cr₹47 Cr₹69 Cr₹24 Cr
Total liabilities₹157 Cr₹166 Cr₹160 Cr₹161 Cr₹156 Cr₹62 Cr
Fixed assets₹37 Cr₹50 Cr₹45 Cr₹39 Cr₹35 Cr₹32 Cr
Capital work in progress₹26 Cr₹13 Cr₹14 Cr₹15 Cr₹15 Cr₹6 Cr
Investments₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹0 Cr
Other assets₹90 Cr₹98 Cr₹97 Cr₹102 Cr₹101 Cr₹23 Cr
Total assets₹157 Cr₹166 Cr₹160 Cr₹161 Cr₹156 Cr₹62 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Mar 2026

Since Mar 2025, promoters added +67.89 pp while the public trimmed −67.89 pp. The shareholder count grew 12% to 1,683.

Promoters
95.0%
Public
5.0%

Since Mar 2025

  • Promoters +67.89 pp
  • Public −67.89 pp
  • DIIs 0.00 pp

How it drifted, 12 quarters

Over this window promoters went from 66.3% to 95.0% — +28.7 pp.

Dec '21Sep '23Mar '26

Ownership split by quarter, oldest first. Dec '21: Promoters 66.3%, Public 33.7%.Mar '22: Promoters 66.3%, Public 33.7%.Sep '22: Promoters 66.3%, Public 33.8%.Dec '22: Promoters 66.3%, DIIs 0.8%, Public 33.0%.Mar '23: Promoters 51.9%, Public 48.2%.Sep '23: Promoters 49.6%, Public 50.4%.Mar '24: Promoters 27.1%, Public 72.9%.Jun '24: Promoters 27.1%, Public 72.9%.Sep '24: Promoters 27.1%, Public 72.9%.Mar '25: Promoters 27.1%, Public 72.9%.Sep '25: Promoters 27.1%, Public 72.9%.Mar '26: Promoters 95.0%, Public 5.0%.

Who was buying across the market this quarter →

Who bought this quarter

since Sep 2025

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 9 off the list — both are in the register beside this.

Who is on the register

Named in the Mar 2026 filing

Every holder of Cian Healthcare Limited above SEBI's 1% disclosure line, and what changed since Sep 2025.

HolderStakeChange
Ananta Medicare Limited 55.00%newly disclosed
Rajesh Kumar Jain 21.00%newly disclosed
Pradeep Kumar Jain 19.00%newly disclosed
Pankaj Shriniwas Zanwar —off the list
Suraj Shriniwas Zanwar —off the list
Prakash Chandra Rathi Huf . —off the list
Shakuntala Shriniwas Zanwar —off the list
Dayal Tours And Travels India Private Limited —off the list
Vikas Kumar Ekka —off the list
Kavita Suraj Zanwar —off the list
Sudhaben Prafulchandra Vaidya —off the list
Sonali Dilip Sanklecha —off the list

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse Cian Healthcare Limited

Guides on how to read this kind of business and the numbers that matter.